Immune checkpoint inhibitor therapy and elevated levels of c-reactive protein associated with covid-19 aggravation in patients with lung cancer

HIGHLIGHTS

SUMMARY

    Severe Acute Respiratory Syndrome Coronavirus (SARSCoV-2) has remained globally endemic since the first case in Wuhan, China, was reported in December 2019. The authors retrospectively examined risk factors for the severity of COVID-19 in patients with lung cancer who were diagnosed with COVID-19 during hospitalization and who had developed or did not develop respiratory failure during the observation period. The median time to the onset of respiratory failure was 8 days in both the high CRP group and ICI within 90 days group, similar to that in a previous report. Although . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?